Since its inception, the Partnership to Improve Patient Care (PIPC) has been strongly opposed to misuse of CER and cost effectiveness in government policies. This proposal appears to have been rushed forward with little or no input from patients and people with disabilities. PIPC urges patients, people with disabilities and their organizations to weigh in with Congress and with CMS to oppose one-size-fits-all policies in Medicare.
We highlight the following significant implications for patients related to Phase 2 of the proposed Part B Drug Payment Model:
- Use of Payer-Centered Assessment Standards and Methods Including Those from the Institute for Clinical and Economic Review
- Focus on One-Size-Fits-All Policy Standards and National Protocols Will Set Back the Drive for Patient-Centeredness and Disadvantage People with Disabilities
- Undermines ACA Protections Against Misuse of CER and CEA in Medicare
- Excluded Patients and People with Disabilities from a Seat at the Table in the Development of a Major Shift in Public Policy